Which has the lower trailing P/E, BIO or MOH?

BIO has the lower trailing P/E: BIO trades at 46.80 and MOH at 1056.84. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIO or MOH?

Over the past five years, MOH grew revenue faster — BIO at a 0.29% CAGR versus MOH at 13.56%.

Is BIO or MOH more profitable?

BIO runs the higher net margin — BIO at 8.59% versus MOH at -0.02%.

How have BIO and MOH total returns compared?

Over the past 10 years, BIO delivered 9.83% and MOH delivered 13.75% annualized total return. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Molina Healthcare, Inc. (MOH)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Molina Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 8, 2026. Differences are shown without an overall score or investment verdict.

BIO

Bio-Rad Laboratories, Inc.

$10.39B

$386.11HealthcareDelayed quote: Sep 4, 2026, 4:00 PM EDT

MOH

Molina Healthcare, Inc.

$10.48B

$200.80HealthcareDelayed quote: Sep 4, 2026, 4:01 PM EDT

Total return — BIO vs MOH

growth of $100 · dividends reinvested · last 10y

BIO +157.1% (+9.9%/yr)MOH +265.1% (+13.8%/yr)MOH compounded faster over this window

BIO MOH

BIO vs MOH: by the numbers

•MOH is the larger company ($10.48B vs $10.39B market cap).
•BIO trades at the lower trailing earnings multiple (46.80 vs 1056.84 P/E), one valuation lens rather than an overall verdict.
•BIO is profitable (8.59% net margin) while MOH runs a net loss (-0.02%).
•MOH grew revenue faster over the past five years (13.56% vs 0.29% CAGR).

Metrics side by side

Valuation

Metric	BIO	MOH
P/E ratio	46.80	1056.84
Forward P/E	40.05	N/A
P/S ratio	4.00	0.23
P/B ratio	1.44	2.47
EV / EBITDA	28.86	19.98
FCF yield	3.41%	2.63%

Profitability

Metric	BIO	MOH
Gross margin	51.90%	13.07%
Operating margin	9.08%	0.66%
Net margin	8.59%	-0.02%
ROE	3.10%	-0.17%
ROIC	1.54%	3.56%

Growth (annualized)

Metric	BIO	MOH
Revenue CAGR (5Y)	0.29%	13.56%
EPS CAGR (5Y)	-26.27%	-4.78%
FCF CAGR (5Y)	-9.65%	-33.88%
Total return CAGR (5Y)	-13.97%	-6.08%

Frequently asked

Which has the lower trailing P/E, BIO or MOH?: BIO has the lower trailing P/E: BIO trades at 46.80 and MOH at 1056.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIO or MOH?: Over the past five years, MOH grew revenue faster — BIO at a 0.29% CAGR versus MOH at 13.56%.
Is BIO or MOH more profitable?: BIO runs the higher net margin — BIO at 8.59% versus MOH at -0.02%.
How have BIO and MOH total returns compared?: Over the past 10 years, BIO delivered 9.83% and MOH delivered 13.75% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full MOH analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Molina Healthcare P/E ratio Bio-Rad Laboratories ROE Molina Healthcare ROE Bio-Rad Laboratories operating margin Molina Healthcare operating margin Bio-Rad Laboratories revenue growth Molina Healthcare revenue growth Bio-Rad Laboratories free cash flow Molina Healthcare free cash flow

Bio-Rad Laboratories & Molina Healthcare appear in these rankings

Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 8, 2026.